Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site

Roberto Burioni, Nicasio Mancini, Donata De Marco, Nicola Clementi, Mario Perotti, Giovanni Nitti, Monica Sassi, Filippo Canducci, Krisha Shvela, Patrizia Bagnarelli, John R. Mascola, Massimo Clementi

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Antibodies against conserved epitopes on HIV-1 envelope glycoproteins (Env), such as the gp120 CD4-binding site (CD4bs), could contribute to protection against HIV-1. Env-based immunogens inducing such a response could be a major component of future anti-HIV-1 strategies. In this proof-of-concept study we describe the generation of two anti-idiotype (AI) murine antibodies mimicking the CD4bs epitope. Sera were collected from long-term non-progressor patients to obtain CD4bs-directed IgG, through sequential purification steps. The purified IgG were then used as Fab fragments to immunize mice for hybridoma generation. Two hybridomas (P1 and P2), reacting only against the CD4bs-directed IgG, were identified and characterized. The P1 and P2 antibodies were shown to recognize the idiotype of the broadly neutralizing anti-CD4bs human mAb b12. Both P1 and P2 Fabs were able to induce a strong anti-gp120 response in rabbits. Moreover, the rabbits' sera were shown to neutralize two sensitive tier 1 strains of HIV-1 in an Env-pseudotype neutralization assay. In particular, 3/5 rabbits in the P1 group and 1/5 in the P2 group showed greater than 80% neutralizing activity against the HXB2 pseudovirus. Two rabbits also neutralized the pseudovirus HIV-MN. Overall, these data describe the first anti-idiotypic vaccine approach performed to generate antibodies to the CD4bs of the HIV-1 gp120. Although future studies will be necessary to improve strength and breadth of the elicited neutralizing response, this proof-of-concept study documents that immunogens designed on the idiotype of broadly neutralizing Abs are feasible and could help in the design of future anti-HIV strategies.

Original languageEnglish
Article numbere3423
JournalPLoS One
Volume3
Issue number10
DOIs
Publication statusPublished - Oct 16 2008

Fingerprint

Human immunodeficiency virus 1
HIV-1
binding sites
Anti-Idiotypic Antibodies
monoclonal antibodies
rabbits
Binding Sites
Monoclonal Antibodies
Rabbits
neutralization
Pseudovirus
antibodies
hybridomas
Antibodies
Immunoglobulin G
Hybridomas
epitopes
Epitopes
HIV
env Gene Products

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site. / Burioni, Roberto; Mancini, Nicasio; De Marco, Donata; Clementi, Nicola; Perotti, Mario; Nitti, Giovanni; Sassi, Monica; Canducci, Filippo; Shvela, Krisha; Bagnarelli, Patrizia; Mascola, John R.; Clementi, Massimo.

In: PLoS One, Vol. 3, No. 10, e3423, 16.10.2008.

Research output: Contribution to journalArticle

Burioni, R, Mancini, N, De Marco, D, Clementi, N, Perotti, M, Nitti, G, Sassi, M, Canducci, F, Shvela, K, Bagnarelli, P, Mascola, JR & Clementi, M 2008, 'Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site', PLoS One, vol. 3, no. 10, e3423. https://doi.org/10.1371/journal.pone.0003423
Burioni, Roberto ; Mancini, Nicasio ; De Marco, Donata ; Clementi, Nicola ; Perotti, Mario ; Nitti, Giovanni ; Sassi, Monica ; Canducci, Filippo ; Shvela, Krisha ; Bagnarelli, Patrizia ; Mascola, John R. ; Clementi, Massimo. / Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site. In: PLoS One. 2008 ; Vol. 3, No. 10.
@article{dc55bb0b229d47a6b98b574cf506f3cc,
title = "Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site",
abstract = "Antibodies against conserved epitopes on HIV-1 envelope glycoproteins (Env), such as the gp120 CD4-binding site (CD4bs), could contribute to protection against HIV-1. Env-based immunogens inducing such a response could be a major component of future anti-HIV-1 strategies. In this proof-of-concept study we describe the generation of two anti-idiotype (AI) murine antibodies mimicking the CD4bs epitope. Sera were collected from long-term non-progressor patients to obtain CD4bs-directed IgG, through sequential purification steps. The purified IgG were then used as Fab fragments to immunize mice for hybridoma generation. Two hybridomas (P1 and P2), reacting only against the CD4bs-directed IgG, were identified and characterized. The P1 and P2 antibodies were shown to recognize the idiotype of the broadly neutralizing anti-CD4bs human mAb b12. Both P1 and P2 Fabs were able to induce a strong anti-gp120 response in rabbits. Moreover, the rabbits' sera were shown to neutralize two sensitive tier 1 strains of HIV-1 in an Env-pseudotype neutralization assay. In particular, 3/5 rabbits in the P1 group and 1/5 in the P2 group showed greater than 80{\%} neutralizing activity against the HXB2 pseudovirus. Two rabbits also neutralized the pseudovirus HIV-MN. Overall, these data describe the first anti-idiotypic vaccine approach performed to generate antibodies to the CD4bs of the HIV-1 gp120. Although future studies will be necessary to improve strength and breadth of the elicited neutralizing response, this proof-of-concept study documents that immunogens designed on the idiotype of broadly neutralizing Abs are feasible and could help in the design of future anti-HIV strategies.",
author = "Roberto Burioni and Nicasio Mancini and {De Marco}, Donata and Nicola Clementi and Mario Perotti and Giovanni Nitti and Monica Sassi and Filippo Canducci and Krisha Shvela and Patrizia Bagnarelli and Mascola, {John R.} and Massimo Clementi",
year = "2008",
month = "10",
day = "16",
doi = "10.1371/journal.pone.0003423",
language = "English",
volume = "3",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site

AU - Burioni, Roberto

AU - Mancini, Nicasio

AU - De Marco, Donata

AU - Clementi, Nicola

AU - Perotti, Mario

AU - Nitti, Giovanni

AU - Sassi, Monica

AU - Canducci, Filippo

AU - Shvela, Krisha

AU - Bagnarelli, Patrizia

AU - Mascola, John R.

AU - Clementi, Massimo

PY - 2008/10/16

Y1 - 2008/10/16

N2 - Antibodies against conserved epitopes on HIV-1 envelope glycoproteins (Env), such as the gp120 CD4-binding site (CD4bs), could contribute to protection against HIV-1. Env-based immunogens inducing such a response could be a major component of future anti-HIV-1 strategies. In this proof-of-concept study we describe the generation of two anti-idiotype (AI) murine antibodies mimicking the CD4bs epitope. Sera were collected from long-term non-progressor patients to obtain CD4bs-directed IgG, through sequential purification steps. The purified IgG were then used as Fab fragments to immunize mice for hybridoma generation. Two hybridomas (P1 and P2), reacting only against the CD4bs-directed IgG, were identified and characterized. The P1 and P2 antibodies were shown to recognize the idiotype of the broadly neutralizing anti-CD4bs human mAb b12. Both P1 and P2 Fabs were able to induce a strong anti-gp120 response in rabbits. Moreover, the rabbits' sera were shown to neutralize two sensitive tier 1 strains of HIV-1 in an Env-pseudotype neutralization assay. In particular, 3/5 rabbits in the P1 group and 1/5 in the P2 group showed greater than 80% neutralizing activity against the HXB2 pseudovirus. Two rabbits also neutralized the pseudovirus HIV-MN. Overall, these data describe the first anti-idiotypic vaccine approach performed to generate antibodies to the CD4bs of the HIV-1 gp120. Although future studies will be necessary to improve strength and breadth of the elicited neutralizing response, this proof-of-concept study documents that immunogens designed on the idiotype of broadly neutralizing Abs are feasible and could help in the design of future anti-HIV strategies.

AB - Antibodies against conserved epitopes on HIV-1 envelope glycoproteins (Env), such as the gp120 CD4-binding site (CD4bs), could contribute to protection against HIV-1. Env-based immunogens inducing such a response could be a major component of future anti-HIV-1 strategies. In this proof-of-concept study we describe the generation of two anti-idiotype (AI) murine antibodies mimicking the CD4bs epitope. Sera were collected from long-term non-progressor patients to obtain CD4bs-directed IgG, through sequential purification steps. The purified IgG were then used as Fab fragments to immunize mice for hybridoma generation. Two hybridomas (P1 and P2), reacting only against the CD4bs-directed IgG, were identified and characterized. The P1 and P2 antibodies were shown to recognize the idiotype of the broadly neutralizing anti-CD4bs human mAb b12. Both P1 and P2 Fabs were able to induce a strong anti-gp120 response in rabbits. Moreover, the rabbits' sera were shown to neutralize two sensitive tier 1 strains of HIV-1 in an Env-pseudotype neutralization assay. In particular, 3/5 rabbits in the P1 group and 1/5 in the P2 group showed greater than 80% neutralizing activity against the HXB2 pseudovirus. Two rabbits also neutralized the pseudovirus HIV-MN. Overall, these data describe the first anti-idiotypic vaccine approach performed to generate antibodies to the CD4bs of the HIV-1 gp120. Although future studies will be necessary to improve strength and breadth of the elicited neutralizing response, this proof-of-concept study documents that immunogens designed on the idiotype of broadly neutralizing Abs are feasible and could help in the design of future anti-HIV strategies.

UR - http://www.scopus.com/inward/record.url?scp=54849437925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54849437925&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0003423

DO - 10.1371/journal.pone.0003423

M3 - Article

VL - 3

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e3423

ER -